Shows & Panels
- Accelerate and Streamline for Better Customer Service
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Client Virtualization Solutions
- Data Protection in a Virtual World
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Feds in the Cloud
- Health IT: A Policy Change Agent
- Improving Healthcare Outcomes through IT Policy
- IT Innovation in the New Era of Government
- Making Dollars And Sense Out of Data Center Consolidation
- Navigating the Private Cloud
- One Step to the Cloud, Two Steps Toward Innovation
- Path to FDCCI Compliance
- Take Command of Your Mobility Initiative
Shows & Panels
Healthcare IT and clinical testing
Tuesday - 3/12/2013, 7:18pm EDT
Many will argue that improving healthcare IT will reduce the cost that Americans pay.
Both of these aspects of the federal government come together when you consider clinical testing.
Clinical testing is, of course, the way new drugs are scientifically tested over a long period of time to assure users that the benefits outweigh the risks.
Today, these tests must comply with regulation from the Food and Drug Administration (FDA).
Today's guest is Tony Varano, the founder and CEO of a company called DSG.
His company has spent the past twenty years working with companies to help them comply with the rigorous processes that the FDA has for vetting medicine.
They have been at 25,000 sites, participated in 1,000 clinical trials, worked with 400 companies in over 90 countries.
During the interview, Varano discusses best practices for collecting data and also gives some suggestions for making improvements in the process.